Plant-based Biologic Market Size is USD 67.4 Million in 2026

The global plant-based biologic market size surpassed USD 62.18 million in 2025 and is predicted to reach around USD 137.94 million by 2035, registering a CAGR of 8.29% from 2026 to 2035. Driven by critical product segments and diverse end-use applications. The world market for recombinant proteins is growing feverishly because of the burden of chronic disease, expansion of biologics, and technology advances.

Plant-based Biologic Market Statical Scope

Cytokine and growth factors remain the top-selling products. Therapeutic applications continue to lead the overall revenue contribution globally. Rising levels of chronic illness among populations, biosimilar development planned after patent expiries, opportunities in personalized medicine, biotechnology innovations, increasing research and development investments, and government policies that support these areas, are all contributing collectively to the strong expansion and performance of the global recombinant proteins market. The challenges that affect the recombination proteins market are: high production and purification costs, challenges in the regulatory pathways facing new therapies, lack of bio-foundries or production infrastructures in certain emerging nations, alternative therapeutic approaches, and lack of medical need in some markets slow the widespread adoption of recombinant proteins and limit global growth. There are a number of promising growth-enhancing areas within the recombinant proteins space, including CRISPR-Cas9 and AI-based protein design, the growth of CMO and contract research organizations outsourcing services, the segment of biosimilars and bio-betters, as well as applications in diagnostics, regenerative medicine, and agriculture.

• In August 2023, Danaher acquired Abcam and expanded its portfolio of recombinant proteins and life science tools. This acquisition further enhances Danaher's research-based applications to lead in recombinant proteins and demonstrates Danaher's focus and commitment to being a market leader in recombinant proteins.

Plant-based Biologic Market Share, By Region, 2025 (%)

• North America – Holds 28.27% of the 2025 market, supported by strong biotechnology infrastructure and government funding. Does not dominate as market maturity limits further expansion.
• Asia Pacific – Accounts for 32.31% of the 2025 market, driven by increasing R&D activity, lower production costs, and growing healthcare demand. Dominates and continues to gain momentum due to rapid technological advancement and supportive regulatory frameworks.
• Europe – Represents 21.47% of the 2025 market, characterized by stringent regulations and a focus on sustainable biologic development. Maintains steady share with consistent innovation in biopharmaceutical research.
• LAMEA – Holds 17.95% of the 2025 market, encompassing Latin America, the Middle East, and Africa. Does not dominate due to limited biotech infrastructure and slow adoption of plant-based biologics.

Plant-based Biologic Market Share, By Type, 2025 (%)

• Genetically Modified – Holds 48.96% of the 2025 market, representing biologics derived from genetically engineered plants for higher yield and precision. Dominates due to technological maturity, scalability, and broader therapeutic applications.
• Non-GMO – Accounts for 51.04% of the 2025 market, focusing on naturally cultivated plants without genetic modification. Does not dominate as it faces limitations in production efficiency and cost-effectiveness compared to GM variants.

Plant-based Biologic Market Share, By Application, 2025 (%)

• Hospital – Commands 33.57% of the 2025 market, covering clinical applications of plant-based biologics in patient treatments and therapies. Dominates owing to high adoption rates in advanced healthcare facilities and established biologic use in therapeutics.
• R&D Institution – Holds 36.10% of the 2025 market, involving research-driven adoption for biologic innovation and testing. Gaining momentum as research investments and biotech collaborations expand globally.
• Others – Represents 30.33% of the 2025 market, including academic, agricultural, and niche commercial uses. Maintains stable presence with steady but limited application scope.